The Sunshine Reporter

West Syndrome Market

DelveInsight’s West Syndrome market report offers detailed information on current treatment practices, emerging drugs, West Syndrome market share of the individual therapies, current and forecasted West Syndrome market size from 2018 to 2030 segmented into 7MM (the US, EU5 (the UK, Spain, Germany, Italy, and France), and Japan). 

Key Takeaways from the West Syndrome Market Report

• As per DelveInsight estimates, total West Syndrome diagnosed prevalent cases were 8,601 in the 7MM in 2020, with the US accounted for the maximum cases 
• Delvelnsight also examined gender-specific data for West Syndrome, which clearly shows that it is more common in men than women.
• Among the EU5 countries, France had the highest diagnosed prevalent cases in 2020.
• Leading companies in the West Syndrome market include Amzell, BioPharm Solutions, Cerecin, and others.
• Key West Syndrome pipeline therapies include AMZ002, JBPOS0101, Tricaprilin, and others.
• The FDA has also granted JBPOS0101 (BioPharm Solutions) Orphan Drug Status for West Syndrome.
• The US FDA has granted AMZ002 (Amzell) Rare Pediatric Disease and Orphan-Drug Designations. 

Request for West Syndrome market report sample to understand more about the emerging drug landscape @ West Syndrome Market Landscape

West Syndrome Overview

West syndrome is an age-related specific epileptic encephalopathy caused by various factors. It is distinguished by a distinct type of seizure known as epileptic (infantile) spasms and gross EEG abnormalities indicative of hypsarrhythmia.

West Syndrome Epidemiology Segmentation

The West Syndrome report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

• West Syndrome Total Prevalent Population
• West Syndrome Total Diagnosed Prevalent Population
• West Syndrome Gender-Specific Diagnosed Prevalent Population

West Syndrome Treatment Landscape

The major West Syndrome treatment options include:

• Corticosteroids and Other off-label therapies
• Acthar Gel Injection (Corticotropin; ACTH)
• Ketogenic Diet
• Sabril (vigabatrin)

West Syndrome Market Outlook

The current therapeutic landscape of West Syndrome in the United States is shaped by current treatment practices and the anticipated introduction of new therapies. According to DelveInsight’s analysts, the West Syndrome market is expected to grow positively during the forecast period, owing primarily to the increased diagnosed prevalence and the launch of upcoming therapies.

Discover more about the future market share of the drugs @ West Syndrome Market Analysis

West Syndrome Pipeline Therapies and Key Companies 

• AMZ002: Amzell
• JBPOS0101: BioPharm Solutions
• Tricaprilin: Cerecin

Table of Contents

Get in touch with our business executive for Healthcare Due Diligence Services

Related Reports

West Nile Encephalitis Market

DelveInsight’s “West Nile Encephalitis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the West Nile Encephalitis, historical and forecasted epidemiology, as well as the West Nile Encephalitis market trends in the 7MM.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/